| Authors: |
Peng J; Phase I Clinical Trial Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, 511447, Guangdong, China.; Drug Clinical Trial Institution, Guangzhou Chest Hospital, Institute of Tuberculosis, Guangzhou Medical University, Guangzhou, China., Chen J; Drug Clinical Trial Institution, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Du XX; Drug Clinical Trial Institution, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Li HJ; Department of Anatomy and Neurobiology, School of Basic Medical Sciences, Central South University, Changsha, China.; Guangdong Raynovent Biotechnology Co., Ltd., Guangzhou, China., Qin RZ; Phase I Clinical Trial Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, 511447, Guangdong, China., Chen SH; Phase I Clinical Trial Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, 511447, Guangdong, China., Liu X; Phase I Clinical Trial Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, 511447, Guangdong, China., Cheng Q; Phase I Clinical Trial Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, 511447, Guangdong, China., Li XM; Phase I Clinical Trial Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, 511447, Guangdong, China., Huang DX; Phase I Clinical Trial Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, 511447, Guangdong, China., Duan L; Phase I Clinical Trial Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, 511447, Guangdong, China., Li MY; Department of Cardiology, Guangzhou Institute of Cardiovascular Disease, Guangdong Key Laboratory of Vascular Diseases, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Wu WZ; Department of Urology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Ye LK; Phase I Clinical Trial Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, 511447, Guangdong, China., Li YY; Guangdong Raynovent Biotechnology Co., Ltd., Guangzhou, China., Xie ZH; Phase I Clinical Trial Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, 511447, Guangdong, China. xzh0302@126.com., Han K; Phase I Clinical Trial Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, 511447, Guangdong, China. cjy-ke@163.com.; Drug Clinical Trial Institution, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. cjy-ke@163.com. |
